-Reuters
Alpine Immune Sciences To Present New Translational Data On Povetacicept And Acazicolcept In Systemic Lupus Erythematosus At American College Of Rheumatology Convergence 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present new